PURPOSE: To describe the etiology and to document the course of severe mitral regurgitation (MR). METHODS: Prospective registry of 272 patients diagnosed with chronic severe MR in an echocardiographic study. RESULTS: Mean age was 70.2 +/- 13.8 years and 143 patients were women (53%). The most frequent causes of regurgitation were rheumatic disease (72 patients; 26%), ischemic etiology (58; 21%), valve prolapse (57; 21%), and dilated cardiomyopathy (49; 18%). A total of 43 patients (16%) died during follow-up (mean 0.9 +/- 0.3 years, total 2,785 patient-months): 30 from cardiac causes, 9 from non-cardiac causes, and 4 from unknown causes. Actuarial transplant-free survival was 87% at 6 months, and 81% at 1 year. Renal disease, previous stroke, ischemic etiology, and poor left ventricular ejection fraction were independent predictors of mortality. CONCLUSIONS: Rheumatic disease is still the main cause of severe MR in Spain. Patients with severe MR have advanced age and present poor short-term prognosis.
PURPOSE: To describe the etiology and to document the course of severe mitral regurgitation (MR). METHODS: Prospective registry of 272 patients diagnosed with chronic severe MR in an echocardiographic study. RESULTS: Mean age was 70.2 +/- 13.8 years and 143 patients were women (53%). The most frequent causes of regurgitation were rheumatic disease (72 patients; 26%), ischemic etiology (58; 21%), valve prolapse (57; 21%), and dilated cardiomyopathy (49; 18%). A total of 43 patients (16%) died during follow-up (mean 0.9 +/- 0.3 years, total 2,785 patient-months): 30 from cardiac causes, 9 from non-cardiac causes, and 4 from unknown causes. Actuarial transplant-free survival was 87% at 6 months, and 81% at 1 year. Renal disease, previous stroke, ischemic etiology, and poor left ventricular ejection fraction were independent predictors of mortality. CONCLUSIONS:Rheumatic disease is still the main cause of severe MR in Spain. Patients with severe MR have advanced age and present poor short-term prognosis.
Authors: L H Ling; M Enriquez-Sarano; J B Seward; T A Orszulak; H V Schaff; K R Bailey; A J Tajik; R L Frye Journal: Circulation Date: 1997-09-16 Impact factor: 29.690
Authors: L H Ling; M Enriquez-Sarano; J B Seward; A J Tajik; H V Schaff; K R Bailey; R L Frye Journal: N Engl J Med Date: 1996-11-07 Impact factor: 91.245
Authors: F Grigioni; M Enriquez-Sarano; L H Ling; K R Bailey; J B Seward; A J Tajik; R L Frye Journal: J Am Coll Cardiol Date: 1999-12 Impact factor: 24.094
Authors: Delphine Detaint; David Messika-Zeitoun; Jean-François Avierinos; Christopher Scott; Horng Chen; John C Burnett; Maurice Enriquez-Sarano Journal: Circulation Date: 2005-05-10 Impact factor: 29.690
Authors: J P Singh; J C Evans; D Levy; M G Larson; L A Freed; D L Fuller; B Lehman; E J Benjamin Journal: Am J Cardiol Date: 1999-03-15 Impact factor: 2.778
Authors: A Marc Gillinov; Eugene H Blackstone; Jeevanantham Rajeswaran; Maurice Mawad; Patrick M McCarthy; Joseph F Sabik; Takahiro Shiota; Bruce W Lytle; Delos M Cosgrove Journal: Ann Thorac Surg Date: 2005-09 Impact factor: 4.330
Authors: Francesco Grigioni; Jean-François Avierinos; Lieng H Ling; Christopher G Scott; Kent R Bailey; A Jamil Tajik; Robert L Frye; Maurice Enriquez-Sarano Journal: J Am Coll Cardiol Date: 2002-07-03 Impact factor: 24.094
Authors: Akhil Narang; Karima Addetia; Lynn Weinert; Megan Yamat; Atman P Shah; John E Blair; Victor Mor-Avi; Roberto M Lang Journal: J Am Soc Echocardiogr Date: 2018-08-07 Impact factor: 5.251